Title:
APPLICATION OF ELLAGIC ACID IN PREVENTING AND TREATING NOVEL CORONAVIRUS INFECTION
Document Type and Number:
WIPO Patent Application WO/2021/212269
Kind Code:
A1
Abstract:
The present invention relates to the technical field of medicines, and relates to a compound for efficiently and specifically preventing and treating novel coronavirus infection and an application thereof. The effective component of the compound comprises ellagic acid and ellagic acid derivatives (comprising but are not limited to analogs such as ellagic acid methylation products and ellagic acid structural modifiers). The effective use concentration range of the compound is 10 ng/ml to 1000 ug/ml or 10 ng/g to 1000 ug/g. The compound is used for product development. The developed product is used for preventing and treating novel coronavirus infection, can specifically weaken the infection capability of novel coronavirus, thereby preventing and treating novel coronavirus infection and reducing the risk of human-to-human transmission.
More Like This:
Inventors:
SHENG JUN (CN)
WANG XUANJUN (CN)
HUANG YEWEI (CN)
XU HUANHUAN (CN)
ZHU QIANGQIANG (CN)
WU XIAOYUN (CN)
WANG XUANJUN (CN)
HUANG YEWEI (CN)
XU HUANHUAN (CN)
ZHU QIANGQIANG (CN)
WU XIAOYUN (CN)
Application Number:
PCT/CN2020/085615
Publication Date:
October 28, 2021
Filing Date:
April 20, 2020
Export Citation:
Assignee:
UNIV YUNNAN AGRICULTURAL (CN)
KUNMING BIOLOGICAL MANUFACTURING RES INSTITUTE CO LTD (CN)
YUNNAN DAYE DIHONG BIOTECHNOLOGY CO LTD (CN)
KUNMING BIOLOGICAL MANUFACTURING RES INSTITUTE CO LTD (CN)
YUNNAN DAYE DIHONG BIOTECHNOLOGY CO LTD (CN)
International Classes:
A61K31/366; A01N43/90; A01P1/00; A41D13/11; A61K8/49; A61P31/14; A61Q17/00; A61Q19/10
Foreign References:
| CN102485231A | 2012-06-06 |
Other References:
YUAN ZHAOHE, ZHAO XUEQING, YIN YANLEI, FENG LIJUAN: "Research Progress on Phytochemicals in Pomegranate", DECIDUOUS FRUITS, vol. 45, no. 5, 31 December 2013 (2013-12-31), pages 1 - 6, XP055860434, ISSN: 1002-2910, DOI: 10.13855/j.cnki.lygs.2013.05.015
OSO BABATUNDE J., OLAOYE I., OMEIKE S.: "Molecular Docking and ADMET Prediction of Natural Compounds towards SARS Spike Glycoprotein-Human Angiotensin-Converting Enzyme 2 and SARS-CoV-2 Main Protease", ARCHIVES OF RAZI INSTITUTE, vol. 76, no. 3, 1 June 2021 (2021-06-01), pages 453 - 459, XP055860436, DOI: 10.22092/ari.2020.351202.1517
OSO BABATUNDE J., OLAOYE I., OMEIKE S.: "Molecular Docking and ADMET Prediction of Natural Compounds towards SARS Spike Glycoprotein-Human Angiotensin-Converting Enzyme 2 and SARS-CoV-2 Main Protease", ARCHIVES OF RAZI INSTITUTE, vol. 76, no. 3, 1 June 2021 (2021-06-01), pages 453 - 459, XP055860436, DOI: 10.22092/ari.2020.351202.1517
Attorney, Agent or Firm:
BEIJING MINGHUA BOXIN INTELLECTUAL PROPERTY AGENCY CO., LTD. (CN)
Download PDF: